OcuCell Announces Funding from the Georgia Eye Bank
OcuCell, a provider of ocular cell therapy, announce funding from the Georgia Eye Bank. Founded in 1961, Georgia Eye Bank has provided over 60,000 corneas for transplant and is dedicated to improving vision and lives through transplantation of ocular tissue and cells.
Financial terms of the deal were not disclosed.
In addition to the funding, Georgia Eye Bank President and CEO Eric Meinecke will join the OcuCell Board of Directors; and its Co-Medical Director, William Barry Lee, MD, will join the OcuCell Scientific Advisory Board. “Georgia Eye Bank has a long and proud history of serving others,” Mr. Meinecke said in an OcuCell news release. “Our organization believes strongly in innovation and collaboration. We are thrilled to be working with OcuCell and looking forward to contributing to its growth and success.”
“Georgia Eye Bank’s investment not only validates our commitment to excellence, but also strengthens our financial footing as we embark on the next phase of ocular cell therapy product development,” said OcuCell President and Co-Founder Chris Stoeger. “We are excited to welcome them and know their extensive knowledge in the eye banking and ocular industry align perfectly with our vision to provide state-of-the-art ocular cell therapy solutions that improve lives.”
OcuCell stated it is actively seeking to collaborate with industry stakeholders, research institutions, and health care partners.